Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.4K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.4K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

686
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
686
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

563
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
563
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

769
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
769
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

634
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
634

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

prepIMS: a robust data preprocessing workflow for ion mobility mass spectrometry imaging.

Analytica chimica acta·2026
Same author

MSInet: A Self-Supervised CNN Framework Integrating Global and Local Context for Robust Mass Spectrometry Imaging Segmentation.

Analytical chemistry·2025
Same author

Left Main Obstruction From Paravalvular Leak Closure Device in Patient With Surgical Aortic Valve Replacement.

JACC. Case reports·2025
Same author

SagMSI: A graph convolutional network framework for precise spatial segmentation in mass spectrometry imaging.

Analytica chimica acta·2025
Same author

Severe Central Nervous System and Respiratory Depression in a Neonate Following Accidental Oral Ingestion of Brimonidine Tartrate.

Cureus·2024
Same author

Pediatric penetrating brain injuries with intact neurological function: Two case reports of a pencil and a toy wheel encounter.

SAGE open medical case reports·2024

Related Experiment Video

Updated: Mar 29, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

15.1K

Malignancies After Heart Transplant.

Noman Lateef1, Kalid Abdul Basit, Nadeem Abbasi

  • 1From the Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|December 9, 2015
PubMed
Summary

Malignancies are a major complication after heart transplant, occurring in 39.1% of patients within 10 years. Immunosuppressive therapy is a key factor, but specific drug links remain unclear.

More Related Videos

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

4.4K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

17.9K

Related Experiment Videos

Last Updated: Mar 29, 2026

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique
10:32

Murine Cervical Heart Transplantation Model Using a Modified Cuff Technique

Published on: October 12, 2014

15.1K
A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model
06:45

A Modified Cuff Technique for Mouse Cervical Heterotopic Heart Transplantation Model

Published on: February 7, 2022

4.4K
Murine Heterotopic Heart Transplant Technique
10:27

Murine Heterotopic Heart Transplant Technique

Published on: July 8, 2014

17.9K

Area of Science:

  • Cardiology
  • Oncology
  • Transplant Surgery

Background:

  • Malignancies are a significant post-heart transplant complication, affecting 39.1% within 10 years.
  • Common malignancies include skin cancers and posttransplant lymphoproliferative disorder in adults, and lymphoma in children.
  • Increased immunosuppressive therapy doses are a primary cause of posttransplant malignancies.

Purpose of the Study:

  • To highlight the incidence and types of malignancies after heart transplant.
  • To underscore the role of immunosuppressive therapy in posttransplant cancers.
  • To identify the need for more data on specific immunosuppressive drug associations with malignancy.

Main Methods:

  • Literature review and data synthesis on post-heart transplant malignancies.
  • Analysis of reported cancer types and incidence rates.
  • Comparison of risk factors between transplant recipients and the general population.

Main Results:

  • Heart transplant recipients have a higher incidence of early-onset, aggressive malignancies compared to the general population.
  • Specific solid tumors like lung, bladder, prostate, oral cavity, stomach, and bowel cancers occur, though rarely.
  • While immunosuppression is implicated, data linking specific drugs to posttransplant cancers are limited.

Conclusions:

  • Malignancies are a critical concern following heart transplantation.
  • Immunosuppressive drug regimens require careful consideration due to cancer risk.
  • Further research is essential to elucidate the relationship between specific immunosuppressants and malignancy development.